Regulation of alpha-1B adrenergic receptor localization, trafficking, function, and stability

被引:25
作者
Toews, ML [1 ]
Prinster, SC [1 ]
Schulte, NA [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmacol, Nebraska Med Ctr 986260, Omaha, NE 68198 USA
关键词
alpha-1 adrenergic receptor; desensitization; internalization; endocytosis; sequestration; down-regulation; upregulation; inherent instability; G protein coupling; site irected mutagenesis; protein kinase C; extracellular signal-regulated kinase; caveolae;
D O I
10.1016/j.lfs.2003.09.024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The alpha-1 adrenergic receptors (alpha(1)ARs) play important roles in normal physiology and in many disease states, and understanding their signaling pathways and regulatory mechanisms is thus of considerable relevance, in particular for identifying pharmacological targets for therapeutic modulation. The expression, function, localization, trafficking, and stability of these receptors are all subject to complex regulation by diverse molecular mechanisms. This article highlights recent studies from our laboratory and others focused on the localization and trafficking of the alpha-1B adrenergic receptor (alpha(1B)AR) subtype and on changes in its stability that are likely to be involved in regulating receptor expression. The role(s) of protein kinase C in alpha(1B)AR sequestration, endocytosis, and extracellular signal-regulated kinase (ERK) activation are summarized, and evidence for alpha(1B)AR localization in caveolae/rafts is presented. Receptor structural domains involved in the multiple steps and mechanisms of agonist-induced desensitization are described. Finally, aspects of alpha(1B)AR structural stability that appear to control its drug-induced up- and down-regulation are discussed. Our understanding of regulation for the alpha(1B)AR subtype provides a model for studies of the differential regulation of the other alpha(1)AR subtypes and may lead to identification of new molecular targets for therapeutic intervention in a variety of disease states. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:379 / 389
页数:11
相关论文
共 56 条
[1]  
Alewijnse AE, 2000, MOL PHARMACOL, V57, P890
[2]   α-Adrenergic inhibition of proliferation in HepG2 cells stably transfected with the α1B-adrenergic receptor through a p42MAPkinase/p21Cip1/WAF1-dependent pathway [J].
Auer, KL ;
Spector, MS ;
Tombes, RM ;
Seth, P ;
Fisher, PB ;
Gao, B ;
Dent, P ;
Kunos, G .
FEBS LETTERS, 1998, 436 (01) :131-138
[3]   Functional consequences of constitutively active alpha 2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes [J].
Betuing, S ;
Valet, P ;
Lapalu, S ;
Peyroulan, D ;
Hickson, G ;
Daviaud, D ;
Lafontan, M ;
SaulnierBlache, JS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) :765-773
[4]   Differences in the cellular localization and agonist-mediated internalization properties of the α1-adrenoceptor subtypes [J].
Chalothorn, D ;
McCune, DF ;
Edelmann, SE ;
García-Cazarín, ML ;
Tsujimoto, G ;
Piascik, MT .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :1008-1016
[5]   Regulatory mechanisms of α1B-adrenergic receptor function [J].
Cotecchia, S ;
Mhaouty-Kodja, S .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 (02) :154-157
[6]  
COWLEN MS, 1987, J PHARMACOL EXP THER, V243, P527
[7]  
COWLEN MS, 1988, MOL PHARMACOL, V34, P340
[8]   Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase [J].
Daaka, Y ;
Luttrell, LM ;
Ahn, S ;
Della Rocca, GJ ;
Ferguson, SSG ;
Caron, MG ;
Lefkowitz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :685-688
[9]   INDUCTION OF MUTANT DYNAMIN SPECIFICALLY BLOCKS ENDOCYTIC COATED VESICLE FORMATION [J].
DAMKE, H ;
BABA, T ;
WARNOCK, DE ;
SCHMID, SL .
JOURNAL OF CELL BIOLOGY, 1994, 127 (04) :915-934
[10]   β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2 [J].
DeFea, KA ;
Zalevsky, J ;
Thoma, MS ;
Déry, O ;
Mullins, RD ;
Bunnett, NW .
JOURNAL OF CELL BIOLOGY, 2000, 148 (06) :1267-1281